NCT00046020

Study Evaluating Venlafaxine ER in Recurrent Depression

An Acute and Continuation Phase Study of the Comparative Efficacy Study of Venlafaxine ER (Effexor® XR) and Fluoxetine (Prozac®) in Achieving and Sustaining Remission (Wellness) in Patients With Recurrent Unipolar Major Depression; Followed by a Long Term Randomized, Placebo-Controlled Maintenance Treatment Study in Patients Treated Initially With Venlafaxine ER

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,096 (actual)
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to review the long-term comparative efficacy of venlafaxine ER in achieving and sustaining remission (wellness) in patients with recurrent major depression

Conditions

• Depressive Disorder, Major
• Recurrence

Interventions

Type	Name	Description
DRUG	Venlafaxine ER

Timeline

• Start date: 2000-08-01
• Primary completion: 2005-10-01
• Completion: 2005-10-01
• First posted: 2002-09-19
• Last updated: 2009-08-14